Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Gastroesophageal Junction Cancer
Related studies linked through entity extraction aliases.
STRENGTH Expansion
- Status
- WITHDRAWN
- Phase
- N/A
A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection
- Status
- TERMINATED
- Phase
- PHASE2
Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage for Esophageal or Junctional Carcinoma.
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric Cancer
- Status
- TERMINATED
- Phase
- PHASE2
FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea
- Status
- COMPLETED
- Phase
- N/A
Afatinib, Paclitaxel, 2nd Line, Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PET/MR-imaging to Differentiate Between Responders and Non-responders Receiving Preoperative Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Nutritional Management Algorithm in Older Patients With Locally Advanced Esophageal Cancer
- Status
- COMPLETED
- Phase
- NA
Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach
- Status
- TERMINATED
- Phase
- PHASE2